Endogenous and exogenous mediators of quercetin bioavailability

Area of Science:

• Nutritional Science
• Cardiovascular Research
• Pharmacokinetics

Background:

• Quercetin is a dietary flavonol linked to reduced cardiovascular disease (CVD) risk in epidemiological studies.
• However, experimental evidence for its cardioprotective effects is inconsistent, partly due to poor and variable bioavailability.
• Understanding bioavailability is crucial for realizing quercetin's health benefits.

Purpose of the Study:

• To review endogenous and exogenous factors limiting quercetin bioavailability.
• To discuss strategies for enhancing quercetin bioavailability for improved in vivo efficacy.
• To highlight knowledge gaps and future research directions.

Main Methods:

• Review of pharmacokinetic studies in clinical and animal models.
• Analysis of factors influencing quercetin absorption and metabolism.
• Synthesis of in vitro and in vivo findings on cardioprotective activities.

Main Results:

• Quercetin exhibits poor and highly variable bioavailability.
• Numerous endogenous and exogenous factors contribute to this limitation.
• Strategies to improve bioavailability are being explored to enhance in vivo cardioprotective effects.

Conclusions:

• Further controlled trials are needed to assess dose-response effects and the impact of enhanced bioavailability on quercetin's cardioprotective activities.
• Investigating the role of quercetin metabolites in mediating health benefits is essential.
• Optimizing quercetin bioavailability may be key to its therapeutic application in managing CVD risk.